Efficacy and safety of levosimendan in acute heart failure patients with different body mass index: a multicenter, retrospective, observational real-world study.

Front Cardiovasc Med · 2026 · PMC13111429 · PMID 42051433

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

In patients with acute heart failure, levosimendan administration was associated with a decreasing trend in plasma NT-proBNP levels, an improvement in left ventricular ejection fraction, and alleviation of cardiac functional impairment and respiratory symptoms.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.